|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2010-6-11
|
|
pubmed:abstractText |
Rheumatoid arthritis (RA) is a systemic autoimmune disease that is characterized by chronic synovial inflammation. Patients with RA have increased risk of infection; this is related to RA itself or the adverse effects of medication. In this report, we describe a case of emphysematous pyelonephritis in a patient with RA associated with AA amyloidosis and steroid-induced diabetes mellitus who was taking corticosteroid and low-dose methotrexate.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1756-185X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
180-3
|
|
pubmed:meshHeading |
pubmed-meshheading:20536605-Aged,
pubmed-meshheading:20536605-Amyloidosis,
pubmed-meshheading:20536605-Arthritis, Rheumatoid,
pubmed-meshheading:20536605-Diabetes Mellitus,
pubmed-meshheading:20536605-Dose-Response Relationship, Drug,
pubmed-meshheading:20536605-Emphysema,
pubmed-meshheading:20536605-Female,
pubmed-meshheading:20536605-Glucocorticoids,
pubmed-meshheading:20536605-Humans,
pubmed-meshheading:20536605-Immunocompromised Host,
pubmed-meshheading:20536605-Immunosuppressive Agents,
pubmed-meshheading:20536605-Methotrexate,
pubmed-meshheading:20536605-Pyelonephritis,
pubmed-meshheading:20536605-Serum Amyloid A Protein
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
A case of emphysematous pyelonephritis in a patient with rheumatoid arthritis taking corticosteroid and low-dose methotrexate.
|
|
pubmed:affiliation |
Department of Gastroenterology and Rheumatology, School of Medicine, Fukushima Medical University, Fukushima, Japan. chiehiro@fmu.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
